153 related articles for article (PubMed ID: 38439530)
1. No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor Liver Transplantation.
Yang G; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Yoon YI; Kang WH; Joo SH; Lee SG
Ann Transplant; 2024 Mar; 29():e942767. PubMed ID: 38439530
[TBL] [Abstract][Full Text] [Related]
2. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
3. Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review.
Parente A; Cho HD; Kim KH; Schlegel A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047199
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation.
Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
J Gastrointest Surg; 2021 Oct; 25(10):2503-2515. PubMed ID: 33532981
[TBL] [Abstract][Full Text] [Related]
5. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: Quantitative prediction using ADV score.
Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):1000-1013. PubMed ID: 33175453
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
[TBL] [Abstract][Full Text] [Related]
8. Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation.
Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Park KM; Song GW; Jung DH; Kim BS; Moon KM
Transplant Proc; 2007 Jun; 39(5):1526-9. PubMed ID: 17580180
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
10. Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions.
Lee SD; Kim SH; Kim YK; Lee SA; Park SJ
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):18-24. PubMed ID: 24463075
[TBL] [Abstract][Full Text] [Related]
11. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
12. Absence of association between pretransplant serum soluble programmed death protein-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma.
Na BG; Kim YK; Hwang S; Lee KJ; Park GC; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Yang H; Yoon YI; Tak E; Park YH; Lee SG
Medicine (Baltimore); 2021 Apr; 100(17):e25640. PubMed ID: 33907121
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
Hu Z; Qian Z; Wu J; Zhou J; Zhang M; Zhou L; Zheng S
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):315-326. PubMed ID: 26382281
[TBL] [Abstract][Full Text] [Related]
16. Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: a retrospective multicentric cohort study.
Kim DG; Hwang S; Lee KW; Kim JM; You YK; Choi D; Ryu JH; Kim BW; Kim DS; Cho JY; Nah YW; Ju MK; Kim TS; Lee JG; Kim MS; Parente A; Kim KH; Schlegel A; Choi SJN; Joo DJ;
Int J Surg; 2024 May; ():. PubMed ID: 38701521
[TBL] [Abstract][Full Text] [Related]
17. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
18. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
[TBL] [Abstract][Full Text] [Related]
19. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
20. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
Kim SH; Lee EC; Na BG; Park SJ
Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
